by EmpathiCSubstanceS | Nov 5, 2020 | Depression
“For me, I feel it really saved my life,” says Numinus CEO, Payton Nyquvest, in a recent interview with CityNews TV. What Nyquvest is referring to is psilocybin, a psychoactive compound found in several species of mushrooms and believed by many to be effective in...
by EmpathiCSubstanceS | Nov 5, 2020 | Depression
The study found that high doses of ketamine can cause a complete shutdown of EEG activity, which could explain the “state of complete oblivion” associated with a K-hole. Researchers attempting to find a cure for Huntington’s disease may have accidentally...
by EmpathiCSubstanceS | Oct 30, 2020 | Depression, Microdosing
Formerly known only to the underground psychedelic community, the practice of taking microdoses of psychedelic drugs for a variety of purported benefits has made its way to the wider mainstream society. Just for starters, microdosers have reported experiencing...
by EmpathiCSubstanceS | Jul 13, 2020 | Anxiety, Depression
MindMed Is Collaborating on a Phase 2 Clinical Trial of LSD For Cluster Headaches with University Hospital Basel’s Liechti Lab BASEL, Switzerland, June 8, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMEDOTCQB: MMEDF), is supporting and...
by EmpathiCSubstanceS | Apr 8, 2020 | Depression
[vc_row type=”in_container” full_screen_row_position=”middle” scene_position=”center” text_color=”dark” text_align=”left” overlay_strength=”0.3″...
by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Anxiety, Bipolar Disorder, Depression
Researching psychedelics to treat addiction Volunteers at some of the country’s leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit .. read from original article For most of...
